Abstract Hair samples were obtained 1-5 months after ingestion of the antimicrobial ofloxacin, which had been given for i or 3 days at the commencement of haloperidol administration, or when its dosage was reduced. The axial distribution of ofloxacin, haloperidol and its active metabolite, reduced haloperidol, was analysed in segments from single strands of hair. Ofloxacin was detected where the content of haloperidol and reduced haloperidol along the hair shaft showed a sharp change, corresponding to the change in dose.
Hair growth rate differs between individuals, and also amongst hair shafts within an individual. In addition, at any given time approximately 15 To of hairs are in the resting stage [20, 21] . Therefore, when we attempt to interpret drug exposure history from the information obtained from hair analysis, uncertainty due to these variables should be resolved.
We have previously shown that the antimicrobial, ofloxacin, is excreted into hair, and that hair growth rate can be determined by the outward movement of the part of the hair containing the drug [12] [13] [14] [15] . In the present study, we show that by combining analysis of haloperidol and ofloxacin from a single hair shaft, ofloxacin can be used as a time marker to determine the dosage history of haloperidol in an individual patient. This is the first report, to our knowledge, in which an ingested drug has been used as a time marker in hair analysis of another drug.
Materials and methods

Materials
Authentic ofloxacin, haloperidol and (_+)-9-fluoro-10-imidazolyl-3-methyl-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3-de] [1,4]benzoxazin-6-carboxylic acid (DL-8357), which was used as the internal standard for ofloxacin, were kindly donated by Daiichi Pharmaceutical Co. (Tokyo, Japan). Reduced haloperidol was a kind gift from Dainippon Pharmaceutical Co. (Osaka, Japan). Chlorohaloperidol, which was used as the internal standard for haloperidol and reduced haloperidol, was purchased from Research Biochemicals Inc. (Natick, MA, U. S. A.). n-Hexane, methanol, chloroform, and acetonitrile were of HPLC grade, and distilled water was repurifled by a Milli-Q SP reagent water system (Nihon Millipore Ltd., Tokyo, Japan). All other reagents were of analytical grade.
Subjects
About 5 strands of hair were obtained from 6 patients (subjects A-F, 4 males and 2 females), aged 33-60 y (mean 42.8 y), weighing 45-66 kg (mean 53.9 kg), who had started taking the antipsychotic, haloperidol (Serenace granules; Dainippon Pharmaceutical dried, each strand was weighed and sectioned into 2-mm-or 1-cmlong pieces successively from the base of the hair root. When the hair root was not visible, the root end was determined by inspection under a microscope.
Co., Linton tablets; Yoshitomi Pharmaceutical Co., Osaka, Japan, or haloperidol 1% granules (Mohan Medicine Research Institute, Tokyo, Japan), in doses of 3-7.5 mg per day 1-5 months prior to hair sampling. At the commencement of haloperidol administration, ofloxacin (Tarivid tablets; Daiichi Pharmaceutical Co.) was prescribed for the treatment of respiratory or urinary infections (300 rag/day, 1-3 days). Hair samples were also collected from two additional patients (subjects G and H, 1 male and 1 female; age 42 and 48 y; body weight 71 and 53 kg), who had taken 300 mg per day ofloxacin for 1 day, when their haloperidol dose was reduced from 30 to 15 mg/day, and from 8 to 4 mg per day, respectively. Informed consent for taking ofloxacin and for sampling hair was obtained from each subject. The study protocol was approved by the local Ethics Committee.
Hair samples
Hair strands were plucked from the occipital region, as hair in this region has more consistent growth rate and less hairs in resting stage [20, 22] . Black hairs were chosen, since the content of drugs is higher [8, 14] . Hair strands were held by fingers and pulled in the direction of hair growth, one by one, to minimize discomfort and to avoid breaking the hair between the root and shaft. Hairs that easily came out were excluded, as they are likely to be in resting stage. Hair samples were washed with a 0.1% (w/v) solution of sodium dodecyl sulfate (SDS) under sonication for 30 rain, followed by thorough rinsing with distilled water. Hairs were blotted between paper towels and allowed to dry in air. When completely
Extraction procedures
The extraction procedures are shown in Fig. 1 . Each piece of hair was put into a 10 ml screw-capped centrifuge tube, and the internal standards, chlorohaloperidol and DL-8357, were added to yield final amounts of 5 and 500 ng per tube, respectively. Then, 2 N sodium hydroxide solution 0.5 ml was added to the tube, and the hair was dissolved by heating at 80°C for 30 min. After the solubilised hair had cooled to room temperature, n-hexane 5 mI containing 1.5 % (v/v) isoamylalcohol was added and the mixture was shaken for 15 min. After centrifugation at 3000 g for 3 min, 4.5 ml of the separated organic layer was transferred into a disposable tube. Aliquots each (4.5 ml) from 5 consecutive 2-mm sections of the same 1-cm segment of hair were placed together in one tube, to represent a 1-cm-long piece of hair. The solvent was evaporated under a gentle stream of nitrogen at 50 °C. The residue was dissolved in 100 ~tl methanol, and 50 ~d was injected into an HPLC system to detect haloperidol and reduced haloperidol.
For samples in which there were peaks interfering with haloperidol and/or reduced haloperidol, additional clean-up was performed using solid-phase columns and the method of Eddington et al. [23] with slight modifications. To the dissolved residue, 50 mM potassium phosphate buffer 1 ml (pH 6.8) was added. The mixture was transferred to a cyanopropyl (CN) Bond Elut column (100 mg/column; Varian, Harbor, CA, USA), which had previously been activated with 1 ml methanol followed by 1 ml distilled water. The column was washed with l ml distilled water followed by 20 % methanol i ml, and vacuum was applied thoroughly to remove the remaining water. The sample was eluted with 100 % along 5 strands of hair taken from Subject A 2 months after co-administration of ofloxacin (300 mg per day for 3 days). Note that hair samples taken from the same subject, at the same time and in the same way, showed different growth rates, and the content of ofloxacin in each hair shaft varied methanol 1 ml and was collected in a disposable tube. The elute was evaporated as above, reconstituted with 100 ~d methanol, and injected into the HPLC system. To the remainder of the mixture of sodium hydroxide and hexane, 2 N hydrochloric acid 0.5 ml, 500 mM potassium phosphate buffer i ml (pH 6.8) and chloroform 5 ml were added. The mixture was shaken for 20 rain, centrifuged at 3000 g for 3 min, and 4.5 ml of the organic layer was transferred to a disposable tube. The solvent was evaporated as above. This time the residue was dissolved in 100 ,al mobile phase for ofloxacin analysis, and 25 ~1 was injected into a different HPLC system.
Chromatography
Haloperidol and reduced haloperidol were simultaneously measured according to the method previously reported [9] . The HPLC system consisted of a system controller, integrator, pump, autoinjector, column oven (SCL-6B, C-R4A, LC-6A, SIL-6B, CTO-6A, respectively; Shimadzu, Kyoto, Japan), and a Coulochem detector with a guard cell and a high-sensitivity analytical cell (5100A, 5020 and 5011, respectively; ESA, Bedford, MA, USA). The guard cell and detectors 1 and 2 of the analytical cell were operated at potentials of +0.85 V, +0.45 V and +0.80 V, respectively. A TSKgel ODS 80-T s column (150 x 4.6 mm i.d.; Tosoh, Tokyo, Japan) was used for separation. The mobile phase consisted of 50 mM potassium phosphate buffer (pH 6.8), acetonitrile and methanol (3 : 2 : 1, v/v/v), and was filtered through a 0.22 um filter (Nihon Millipore Ltd.) under reduced pressure. The flow rate was 0.8 ml. min -1, and the oven temperature was 40 °C. The quantification limit of haloperidol and reduced haloperidoI were 0.25 ng per tube. At this content the CV's were acceptable (< 20 %), whereas at a lower content the CV's were higher. Figure2 shows representative chromatograms of hair segments from a patient.
Ofloxacin was analysed on a separate HPLC system consisting of a system controller, integrator, pump, autoinjector, column oven and a fluorescence spectrophotometer (SCL-6B, C-R4A, LC-9A, SIL-6B, CTO-6A, RF-5000, respectively; Shimadzu), with excitation and emission wavelengths at 295 nm and 460 nm, respectively. A TSKgel ODS 120-T column (250 × 4.6 mm i.d.; Tosoh) column was used with a TSKgurdgel ODS-120T guard column (15 x 4.6 mm i. d.; Tosoh). The mobile phase was a mixture of 50 mM potassium phosphate buffer (pH 2.5) and acetonitrile (83 : 17, v/v), filtered as above. The flow rate and oven temperature were the same as for haloperidol/reduced haloperidol. The quantification limit of ofloxacin was 0.5 ng per tube (CV < 20 %).
Results
The first hair strand of each subject was successively sectioned into 1 cm lengths from the root and was analysed for ofloxacin, haloperidol and reduced haloperidol. These results roughly showed the hair portion containing ofloxacin. At the same time, it was found that hair samples from 6 of the 8 subjects required to be cleaned -up by including the solid-phase procedure before measuring haloperidol and reduced haloperidol.
The remaining strands from each subject were sectioned into 2-ram-long segments in the 2-3 cm-long zones in which ofloxacin was expected to be detected. The remainder of the hair was sectioned into 1-cm-long pieces.
When hair was collected from the 6 subjects who had taken ofloxacin 300 mg per day for 1 or 3 days at the time when the administration of haloperidol had been started, the appearance of haloperidol and reduced haloperidol along the hair length coincided with the 2-mm segments where ofloxacin was detected. The distribution of haloperidol, reduced haloperidol and ofloxacin along the second strand of hair from 4 subjects (A-D) is shown in Fig. 3 . Even when the growth rate differed, we could still demonstrate a particular segment on each hair that corresponded to a known date. The distribution of ofloxacin along 5 strands of hair taken from Subject A 2 months after the commencement of haloperidol are shown in Fig. 4 . Even for hairs taken from the same subject, at the same time and in the same way, the segments where ofloxacin was detected varied, indicating that each strand of hair had a different growth rate. The content of ofloxacin in each shaft also varied.
The distribution of haloperidol, reduced haloperidol and ofloxacin along hair samples collected from Subject E 1 months (left) and 4 months (right) after the co- shaft coincided with the rise and fall in the doses of haloperidol. This indicates that the rate of hair growth, as estimated by ofloxacin, is fairly constant and can be used to calibrate the time at different parts of the hair shaft.
administration of ofloxacin and haloperidol are depicted in Fig.5 . As time passed, the segments with ofloxacin moved towards the tip of hair, together with the segment in which haloperidol and reduced haloperidol appeared. The number of segments containing ofloxacin did not increase with time.
In the two subjects (G and H) who received ofloxacin at the time when their haloperidol dose was halved, ofloxacin was detected in the zone along the hair shaft where the content of haloperidol and reduced haloperidol also fell (Fig. 6) .
In Subject F the dosage of haloperidol was changed several times and it was then discontinued by his psychiatrist; the patient had taken, ofloxacin at the commencement of haloperidol administration. By using ofloxacin as a time marker in hair, the growth rate of the hair shown in Fig. 7 , which was sampled almost 5 months after the administration of ofloxacin, can be estimated as 1.35 cm/month. The upper graph shows the haloperidol dosages on a time scale matched to the estimated growth rate of this strand. The pattern of distribution of haloperidol and reduced haloperidol along the hair
Discussion
We have shown that an ingested drug, whether administered continuously or intermittently, is deposited in hair in proportion to the dose and that it is captured there, moving outwards along the shaft as the hair grows [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Therefore, it may be possible to consider a strand of hair as a "tape-recorder," which continuously stores all the data about the drug exposure of individual over the past several months, or possibly years. Usually body fluids such as blood, urine or saliva are used to monitor drug exposure. However, drug levels in these fluids only reflect the dose taken at the most within several days prior to the sampling. Scalp hairs can provide information over longer periods of time, such as weeks or months, data that could otherwise be obtained only by repeated sampling, or they can provide retrospective information in patients who have not been monitored.
However, this "tape-recorder" has its own "tapespeed", which corresponds to the growth rate of each hair, and which is variable both between and within subjects [15, 24] . In addition, each hair has its own growth cycle of about 2 to 8 years or more [25, 26] , including the resting stage (telogen), which lasts for 3-4 months 25] . If a hair in telogen is sampled, a shift in the distribution of the substance(s) may be found, that may correspond to a period of several months. Therefore, the validity of any results must always be cautiously considered, especially if there is the possibility that hairs in the resting stage might have been sampled. We tried to avoid sampling telogen hairs by using the technique described above. Nevertheless, we did not obtain hairs with exactly the same growth rates. There are several ways to measure hair growth, such as shaving, bleaching, staining or using radioisotopes [21] . Some of the methods are not practicable in clinical use, and some cannot be used for the same hair strands that are to be analysed for drugs. When deriving a drug exposure history, it is desirable to minimise the problem of intra-individual variation in growth rate and to provide a calibrator corresponding to a specific time. It would be best to employ a time marker that could be detected in the same strand(s) of hair that is used for measuring the drug (and/or its metabolite). As we have shown previously, ofloxacin can be used as a time marker to measure hair growth [15] . In the present study we have applied ofloxacin in practice as a time marker to monitor haloperidol ingestion by hair analysis.
We have made refinements in analytical methods to make this approach clinically useful. When a subject had been taking several drugs (especially antipsychotic drugs) in combination, some have been found to interfere with the analysis of haloperidol/reduced haloperidol. For this reason we introduced a clean-up step and changed the internal standard from bromperidol [9] to chlorohaloperidol [23] . We have also developed a procedure that allows us to extract the maximum amount of haloperidol and reduced haloperidol from a limited volume sample, whilst still extracting ofloxacin from the same sample.
In terms of the analysis of ofloxacin, we sectioned a single hair into 2-mm-long pieces, each of which corresponded to about 5 days of growth, when the growth rate of the hair was 1.12 cm/months [15] . As in our previous study [15] , ofloxacin could be detected in 2-mmlong segments of a single hair, and that, ingested for 1 to 3 days, it could be detected in only a few consecutive 2 mm lengths of hair. Ofloxacin exhibited a narrow peak which was not broadened even 5 months after its ingestion. These segments coincided with the appearance or the fall in the haloperidol and reduced haloperidol content along the hair shaft. Therefore, the distribution of ofloxacin along hair served as a time marker and had a reasonably high power of time discrimination. 1 Fig.7 Distribution of haloperidol, reduced haloperidol and ofloxacin along a single hair taken from a subject F, whose dose of haloperidol was frequently changed and was then discontinued. By using ofloxacin as a time marker in hair, the growth rate of this strand of hair can be estimated as 1.35 cm per month. The upper graph shows the past history of his haloperidol dosage on a time scale matched to the estimated growth rate of this strand By using ofloxacin as a time marker, we found that some of the hairs were in the resting stage, the longest being for more than 3 months (data not shown). Some discrepancies in our previous reports [6, 13] could be explained by the artifact induced by sampling hairs in telogen.
Analysis of haloperidol and reduced haloperidol from a single hair was limited to hair segments of 1 cm length, due to their low content in hair. Therefore, the values obtained were the mean of the haloperidol or reduced haloperidol content in each 1 cm length of hair. As the average growth rate of human scalp hair is roughly 1 cm per month [15, 24, 27] , each measurement represented the integrated exposure to haloperidol over a period of about 1 month. The drug content may differ between subjects and even within a subject, depending on the thickness and weight of the hair and the amount of melanin in it [8, 14, 17, 18] . Nevertheless, 201 within the same hair shaft, the content of a drug is proportional to the dosage taken (Fig. 6, 7) [9, 11, 15] .
It may seem preferable, from the viewpoint of assay sensitivity, to measure drugs by combining segments from a number of hair shafts. This may make it possible to divide hairs into shorter lengths, thus obtaining finer discrimination of the changes in drug exposure. However, the result will then be the sum of the drug content of segments from all the hair shafts, each with a variable growth rate, and some possibly being in the resting stage. They may also differ in drug content (Fig. 4) , depending on the weight of the hair and its melanin content. Therefore, data from pooled segments obtained from different hairs may well produce a broadened distribution, with tailing at the point of any change in drug exposure [16] . In addition, it is easier to sample just a few hair strands, because plucking them does cause some discomfort. When the objective of monitoring is to determine the compliance or dosage history of a continuously administered drug, such as haloperidol, knowing the integrated exposure to the drug over a longer period of time, such as a month, may be acceptable.
In the present study, we have used ofloxacin as a time marker for hair analysis of haloperidol and reduced haloperidol to assess the past dosage history of haloperidol and/or compliance with its administration. Ofloxacin may also be useful as a time marker in hair analysis of other drugs and event other substances, just a glycosylated protein can be used to assess blood glucose control in diabetic patients [28] .
